Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 28:14:2127-2136.
doi: 10.2147/IJGM.S312058. eCollection 2021.

Plasma Endogenous Sulfur Dioxide: A Novel Biomarker to Predict Acute Kidney Injury in Critically Ill Patients

Affiliations

Plasma Endogenous Sulfur Dioxide: A Novel Biomarker to Predict Acute Kidney Injury in Critically Ill Patients

Yijia Jiang et al. Int J Gen Med. .

Abstract

Purpose: Sulfur dioxide (SO2) is a novel gaseous signaling molecule that plays an important role in inflammation, which contributes the pathogenesis of acute kidney injury (AKI). The aim of this study was to explore the predictive value of plasma SO2 for AKI in high-risk patients.

Patients and methods: A prospective cohort of 167 patients who underwent major noncardiac surgery was enrolled in the study. Plasma SO2, urine neutrophil gelatinase-associated lipocalin (NGAL), tissue inhibitor of metalloproteinase-2 (TIMP-2), and insulin-like growth factor-binding protein 7 (IGFBP7) levels were detected immediately after the operation. The primary endpoint was new-onset AKI within 72 h after admission. The ability of biomarkers including SO2 and a clinical risk model to predict AKI was compared by receiver operator characteristic (ROC) curve analysis and decision curve analysis (DCA), additional contributions were evaluated by integrated discrimination improvement (IDI) and net reclassification improvement (NRI) analyses.

Results: A total of 61 (36.5%) patients developed AKI within 72 h of surgery. Compared to NGAL and [TIMP-2]·[IGFBP7], SO2 showed better predictive ability for new-onset AKI with an area under the ROC curve of 0.771 (95% confidence interval: 0.700-0.832, p<0.001). The improvement in predictive value by including SO2 in the clinical risk model was supported by NRI (0.28; P=0.04) and IDI (0.15; P<0.001) analyses. The net benefit of the combination of SO2 and clinical variables was the max in DCA.

Conclusion: Plasma SO2 shows a useful value for predicting new-onset AKI, and improved AKI prediction based on clinical variables, which can guide the implementation of preventive measures for high-risk patients.

Keywords: AKI; gasotransmitter; intensive care unit; predictive modelling.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Figure 1
Figure 1
Discrimination of plasma SO2 between non-AKI and AKI of different severities. ***Comparison between non-AKI and AKI of different severities (p<0.001).
Figure 2
Figure 2
Predictive value of plasma SO2 and urine biomarkers for new-onset AKI.
Figure 3
Figure 3
Decision curve for prediction of new-onset AKI using different prediction models.

Similar articles

Cited by

References

    1. Hoste EAJ, Bagshaw SM, Bellomo R, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI‑EPI study. Intensive Care Med. 2015;41:1411–1423. doi:10.1007/s00134-015-3934-7. - DOI - PubMed
    1. Ronco C, Bellomo R, Kellum JA. Acute kidney injury. Lancet. 2019;394:1949–1964. doi:10.1016/S0140-6736(19)32563-2. - DOI - PubMed
    1. Palevsky PM, Liu KD, Brophy PD, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am J Kidney Dis. 2013;61:649–672. doi:10.1053/j.ajkd.2013.02.349. - DOI - PubMed
    1. Ronco C, Bellomo R, Kellum JA. Understanding renal functional reserve. Intensive Care Med. 2017;43:917–920. doi:10.1007/s00134-017-4691-6. - DOI - PubMed
    1. Lehner GF, Forni LG, Joannidis M. Oliguria and biomarkers of acute kidney injury: star struck lovers or strangers in the night? Nephron. 2016;134:183–190. doi:10.1159/000447979. - DOI - PubMed